Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00827333 · ClinicalTrials.gov registry record · NA

Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer

A NA study, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
372
Enrollment target

NCT00827333: Completed NA study, sponsored by City of Hope Medical Center.

NCT00827333 is a NA study that has completed, run by City of Hope Medical Center. The registered enrollment target is 372 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00827333, a NA study, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
372 participants
Enrollment target

Study Summary

RATIONALE: Palliative care teaching sessions may be more effective than standard care in improving caregiver burden, caregiver skills preparedness, quality of life, and distress in family caregivers of patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying the effects of palliative care teaching sessions in family caregivers of patients with non-small cell lung cancer.

Interventions

  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • OTHER educational intervention
  • PROCEDURE psychosocial assessment and care
  • PROCEDURE end-of-life treatment/management

Trial Details

FieldValue
Enrollment Target 372 participants
Start Date 2009-09
Est. Completion 2014-09
Phase NA
City of Hope Medical Center

582 total trials

What the finished NCT00827333 record still lists

NCT00827333 is an interventional study that assigns participants to a tested intervention. The registered 372 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).

The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.

NCT00827333 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00827333 about?

NCT00827333 is a clinical study titled "Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer". RATIONALE: Palliative care teaching sessions may be more effective than standard care in improving caregiver burden, caregiver skills preparedness, quality of life, and distress in family caregivers of patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying the effects of...

What is the current status of trial NCT00827333?

This trial is currently completed. It is a NA study. The enrollment target is 372 participants. The study started on 2009-09. Estimated completion is 2014-09.

What interventions are being tested in trial NCT00827333?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), educational intervention (OTHER), psychosocial assessment and care (PROCEDURE), end-of-life treatment/management (PROCEDURE).

Who is sponsoring clinical trial NCT00827333?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00827333's enrollment target sits among peer trials

372 280th of 2000 higher than 1,720 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04801589 · 372 participants · Phase 3

    Goal-Directed Sedation in Mechanically Ventilated Infants and Children

  • NCT04879329 · 372 participants · Phase 2

    A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • NCT05318105 · 372 participants · NA

    Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

  • NCT06797635 · 372 participants · Phase 2

    Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00827333, the US trial registry maintained by the National Library of Medicine. NCT00827333 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.